Elite Pharmaceuticals Inc (ELTP)

[WeeZuhl]

LOL

I checked their website and, to my surprise, missing from among the drugs Nostrum listed in their product portfolio were the four drugs they bought from Elite! How is it that Nostrum could fail to see the obvious revenue generating benefits of the four $50-100M drugs they bought from Elite?

...


The only thing left to say is PERIOD!

Before using any superlative punctuation, one may wish to familiarize themselves with the FDA's site transfer process. For example, Elite applied for site transfers for dantrolene and loxapine in early 2017. They received approval and launched dantrolene more than *two years later* in 2019. They just recently received the approval for loxapine and have not yet launched it. It is unrealistic to expect Nostrum to commercialize multiple ANDA's within a year of acquiring them (Nov 2019), and it is just plain silly to make ill-conceived conclusions about the ultimate commercial viability of those ANDA's.


Nostrum may have played Nasrat like a fiddle, but the FDA sings to a different tune.